BOLT vs CHPT · rev $7.7M vs rev $417.1M
Bolt Biotherapeutics (BOLT) versus ChargePoint Holdings Inc (CHPT) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
BOLT currently screens at market cap $11.3M. CHPT currently screens at market cap $199.2M.
Not investment advice. Open the BOLT and CHPT stock pages for the full models.
Not investment advice.